TEX13A

Across TCGA pan-cancer cohorts, TEX13A Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated TEX13A data layer compared with 13 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher TEX13A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TEX13A expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

ESCA, BLCA, and KICH are the cancer types where TEX13A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.143	0.707	<.001	48	view →
BLCA	DFS	Median	All	0.168	0.617	.003	24	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
ACC	OS	Median	All	0.147	0.685	.018	12	view →
TGCT	DFS	Median	All	0.002	0.837	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	DFS	Median	IV	0.040	0.454	.028	6	view →
LUSC	DFS	Median	II,III,IV	1.000	0.369	.014	4	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

TEX13A–ESCA (OS)

Open the ESCA breakdown →